Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
Clinical trial NCT07019012 · RECRUITING
Trial details
- NCT number
- NCT07019012
- Sponsor
- Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2026-10-30
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.